ICD-10-CM Billable Code

F15.19

Other stimulant abuse with unspecified stimulant-induced disorder

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F15.19 refers to a condition where an individual experiences problems related to the abuse of stimulants, but the exact type of stimulant causing the disorder is not specified. This code covers cases where stimulant misuse leads to health complications, affecting various bodily functions and mental health. Recognizing this condition is vital for proper management and treatment, provided it is diagnosed by healthcare professionals. This overview offers an accessible explanation of the disorder, its causes, symptoms, diagnosis methods, and general treatment approaches.

Causes & Symptoms

Clinical Causes: Repeated use of stimulant substances such as amphetamines, methamphetamines, or other synthetic stimulants. Using stimulants recreationally for euphoria, increased energy, or other psychosocial reasons. Dependence developed due to ongoing use, leading to compulsive consumption despite adverse effects. Psychological factors such as stress, peer pressure, or underlying mental health conditions. Availability and accessibility of stimulant drugs in certain environments or communities.

Key Symptoms: Increased alertness, energy, and activity levels. Elevated heart rate and blood pressure. Insomnia or difficulty sleeping. Reduced appetite leading to weight loss. Euphoria or feelings of extreme happiness. Anxiety, agitation, or restlessness. Possibility of hallucinations or paranoia in severe cases. Dependence signs such as cravings and withdrawal symptoms if use is stopped. Behavioral changes like reckless decision-making or social withdrawal. Physical health issues such as chest pain or cardiovascular problems.

Diagnostic & Treatment

Diagnosis Path: Healthcare providers typically evaluate the patient's medical history, substance use patterns, and behavioral changes. Diagnostic criteria discussed during clinical assessment include the extent of stimulant use, the presence of physical or mental health problems, and any signs of dependence or withdrawal. Laboratory tests like urine or blood screenings may also be used to confirm recent stimulant use. Additionally, mental health assessments can help identify any co-occurring disorders that might influence treatment strategies.

Treatment Protocols: Although specific treatment plans should be tailored by healthcare professionals, common approaches for stimulant abuse include: - Behavioral therapies such as cognitive-behavioral therapy (CBT) to address psychological dependence. - Support groups that provide peer support. - Medical interventions for managing withdrawal symptoms and co-occurring mental health conditions. - Long-term counseling for underlying issues that contribute to substance use. - Monitoring and relapse prevention strategies. Attending a comprehensive treatment program increases the likelihood of recovery and helps individuals develop healthier coping mechanisms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F15.19 a billable ICD-10 code?
Yes, F15.19 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F15.19?
Clinical documentation must specify the nature of Other stimulant abuse with unspecified stimulant-induced disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference